Transcatheter Aortic Valve Implantation: Review and Current State Of The Art - European Medical Journal

Transcatheter Aortic Valve Implantation: Review and Current State Of The Art

Download PDF
*Valérie Collas,1 Tine Philipsen,2 Inez Rodrigus,2 Christiaan Vrints,1 Bernard P. Paelinck,1 Johan Bosmans1

Prof Bosmans is a part-time clinical proctor for Medtronic CoreValve.

EMJ Int Cardiol. ;1[1]:52-61. DOI/10.33590/emjintcardiol/10313636.
Aortic valve stenosis, valvular heart disease, prosthetic valves, transcatheter aortic valve implantation (TAVI), stroke, aortic regurgitation, vascular complications, permanent pacemaker

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.


Since the introduction of transcatheter aortic valve implantation (TAVI) 12 years ago, the treatment options for severe, symptomatic aortic valve stenosis in high-risk patients have significantly increased. Because of the growing implementation of TAVI in clinical practice, knowledge of the outstanding clinical outcome of TAVI and TAVI-related limitations is expanding. In this review, potential complications, including stroke, vascular complications, paravalvular regurgitation, and conduction disturbances, are discussed. To reduce the incidence of these limitations, new valves are being designed and clinically evaluated. The ultimate goal is to reduce potential complications and expand the use of TAVI to lower-risk patient cohorts.

Please view the full content in the pdf above.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now